Analysis on risk factors for cervical cancer using induction technique

Expert Systems with Applications

Volumn 27, Issue 1, 2004, Pages 97-105

  Ho, Seung Hee ^a   Jee, Sun Ha ^b   Lee, Jong Eun ^c   Park, Jong Sup ^d  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b Yonsei University   (South Korea)

^c DNA Link Inc   (South Korea)

^d The Catholic University of Korea   (South Korea)

Author keywords

Cervical cancer; Genetic polymorphism; Induction technique; Risk factor

Indexed keywords

ALGORITHMS; DATA MINING; DECISION SUPPORT SYSTEMS; DISEASE CONTROL; GENETIC ENGINEERING; IMMUNOLOGY; REGRESSION ANALYSIS; RISK ASSESSMENT; TOBACCO; TUMORS;

CERVICAL CANCER; GENETIC POLYMORPHISM; INDUCTION TECHNIQUE; RISK FACTORS;

EXPERT SYSTEMS;

EID: 2342620776     PISSN: 09574174     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eswa.2003.12.005     Document Type: Article

References (34)

1. Anderson S., Rylander E., Strand A., Sallstrom J., Wilander E. The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas. British Journal of Cancer. 85:2001;1153-1156.
2. Bose I., Mahapatra R.K. Business data mining: a machine learning perspective. Information and Management. 39:2001;211-225.
3. Braun V., Gavey N. With the best of reasons: cervical cancer prevention policy and the suppression of sexual risk factor information. Social Science and Medicine. 48:1999;1463-1474.
4. Burger M., Hollema H., Gouw A.H. Cigarette smoking and human papillomavirus in patients with reported cervical cytological abnormality. British Medical Journal. 306:1993;749-755.
5. Chae Y.M., Ho S.H., Cho K.W., Lee D.H., Ji S.H. Data mining approach to policy analysis in a health insurance domain. International Journal of Medical Informatics. 62:2001;103-111.
6. Cox J.T. Epidemiology of cervical intraepithelial neoplasia: the role of human papillomavirus. Clinical Obstetrics and Gynecology. 9:1995;1-37.
7. Crum C.P. Contemporary theories of cervical carcinogenesis: the virus, the host, and the stem cell. Molecular Pathology. 13:2000;243-251.
8. Dybikowska A., Dettlaff A., Konopa K., Podhajska A. p53 codon 72 polymorphism in cervical cancer patients and healthy women from Poland. Acta Biochemistry. 47:2000;1179-1182.
9. Ferenczy A., Franco E. Persistent human papillomavirus infection and cervical neoplasia. Lancet. 3:2002;11-16.
10. Hair J.F., Anderson R.E., Tatham R.L., Black W.C. Multivariate data analysis. 1998;Prentice-Hall, Englewood Cliffs, NJ.
11. Harada H., Fujita T., Miyamoto M., Kimura Y., Maruyama M., Furia A., Miyata T., Taniguchi T. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell. 58:1989;729-739.
12. Harada H., Kitagawa M., Tanaka N., Yamamoto H., Harada K., Ishihara M., Taniguchi T. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science. 259:1993;971-974.
13. Herrero R., Brinton L.A., Reeves W.C. Sexual behavior, venereal diseases, hygiene practices, and invasive cervical cancer in a high risk population. Cancer. 65:1990;380-386.
14. Herzog T.J. New approaches for the management of cervical cancer. Gynecologic Oncology. 90:2003;S22-S27.
15. Ho S.H., Chae Y.M., Choi M.Y., Song M.R. Study on the development of critical pathway for the cesarean section using data mining technique. Korean Journal of Medical Informatics. 8:(2):2002;41-50.
16. Janicek M.F., Averette H.E. Cervical cancer: prevention, diagnosis, and therapeutics. A Cancer Journal for Clinicians. 51:2001;92-114.
17. Koutsky L.A., Holmes K.K., Critchlow C.W. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. New England Journal of Medicine. 327:1992;1272-1280.
18. Long W.J., Griffith J.L., Selker H.P., D'Agostino R.B. A comparison of logistic regression to decision-tree induction in a medical domain. Computer Biomedical Research. 26:1993;74-97.
19. Major J.A., Riedinger D.R. A hybrid knowledge/statistical-based system for the detection of fraud. International Journal of Intelligent System. 7:1992;687-703.
20. Melikian A., Sun P., Prokopczyk B. Identification of benzopyrene metabolites in cervical mucus and DNA adducts in cervical tissues in humans by gas chromatography-mass spectrometry. Cancer Letters. 146:1999;127-134.
21. Michael J.A., Gordon S.L. Data mining technique: for marketing, sales and customer support. 1997;Wiley, New York.
22. Minoguchi T., Kanamori Y., Matsushima M. No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus infection. Cancer Research. 58:1998;4585-4586.
23. Montani S., Bellazzi R. Intelligent knowledge retrieval for decision support in medical applications. Proceedings of the Annual Meeting of the American Medical Informatics Association. 2001;. pp. 498-502.
24. National Statistical Office (2001). Annual report on the causes of death statistics.
25. Park J.S., Kim E.J., Kwon H.J., Hwang E.S., Namkoong S.E., Um S.J. Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 protein; Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis. Journal of Biology Chemistry. 275:2000;6764-6769.
26. Pendharkar P.C., Rodger J.A., Yaverbaum G.J., Herman N., Benner M. Association, statistical, mathematical and neural approaches for mining breat cancer patterns. Expert Systems with Applications. 17:1999;223-232.
27. Roh J.W., Kim M.H., Kim J.W., Park N.H., Song Y.S., Kang S.B., Lee H.Y. Polymorphism in codon 31 of p21 and cervical cancer susceptibility in Korean women. Cancer Letters. 165:2001;59-62.
28. Spangler W., May J.H., Vargas L.G. Choosing data-mining methods for multiple classification: representational and performance measurement implications for decision support. Journal of Management Information System. 16:(1):1999;47-62.
29. Stilou S., Bamidis P.D., Maglaveras N., Pappas C. Mining association rules form clinical database: An intelligent diagnosis process in healthcare. Proceedings of the Annual Meeting of the American Medical Informatics Association. 2001;. pp. 1399-1403.
30. Stoler M.H. Human papillomaviruses and cervical neoplasia: a model for carcinogenesis. International Journal of Gynecology Pathology. 19:2000;16-28.
31. Storey A., Thomas M., Kalita A., Harwood C., Gardiol D., Mantovani F., Breuer J., Irene M., Matlashewski G., Banks L. Role of a 53 polymorphism in the development of human papillomavirus associated cancer. Nature. 393:1998;229-234.
32. Waggoner S.E. Cervical cancer. Lancet. 361:2003;2217-2225.
33. Wong Y.F., Chung T.K., Cheung T.H., Nobori T., Hampton G.M., Wang V.W., Li Y.F., Chang A.M. p53 polymorphism and human papillomavirus infection in Hong Kong women with cervical cancer. Gynecologic and Obstetric Investgation. 50:2000;60-63.
34. Yang Y.C., Chang C.L., Chen M.L. Effect of p53 polymorphism on the susceptibility of cervical cancer. Gynecologic and Obstetric Investgation. 51:2001;197-201.